Moffitt Cancer Center Partners With Reimagine Care
Goal is for patients to receive ‘seamless, comprehensive care, whether at the clinic or at home,’ said Tim Hembree, D.O., Ph.D., chief quality officer at Moffitt
Read More
Payers Possess the Tools to Tackle Rising Healthcare Costs
By embracing available data, cutting-edge technology, and an intelligent marketplace, payers can design solutions that optimize costs across the entire healthcare ecosystem. The post Payers Possess the Tools to Tackle Rising Healthcare Costs appeared first on MedCity News.
Democratizing Access to Care: The Rise of Virtual Centers of Excellence
A new model of virtual care is emerging that promises to better democratize healthcare access for millions of Americans and revamp our care delivery system with a focus on value and efficiency. The post Democratizing Access to Care: The Rise of Virtual Centers of Excellence appeared first on MedCity News.
LGBTQ+ Health Policy
This Health Policy 101 chapter explores LGBTQ+ people’s identities and demographics, their experiences with health and health care, including the significant disparities, and the related health policy landscape.
California Voters Consider Tough Love for Repeat Drug Offenders
SACRAMENTO, Calif. — California voters are considering whether to roll back some of the criminal justice reforms enacted a decade ago as concerns about mass incarceration give way to public anger over property crime and a fentanyl crisis that has plagued the state since the covid-19 pandemic hit. Proposition 36, on the November ballot, would…
The Medicare Advantage Influence Machine
Federal officials resolved more than a decade ago to crack down on whopping government overpayments to private Medicare Advantage health insurance plans, which were siphoning off billions of tax dollars every year. But Centers for Medicare & Medicaid Services officials have yet to demand any refunds — and over the years the private insurance plans…
Sanofi and Regeneron Biologic Drug Dupixent Notches a New FDA Approval in COPD
Dupixent, a Sanofi and Regeneron Pharmaceuticals drug, is now approved for chronic obstructive pulmonary disease (COPD), a progressive lung disease prevalent in smokers. It’s the sixth FDA-approved indication for the blockbuster drug. The post Sanofi and Regeneron Biologic Drug Dupixent Notches a New FDA Approval in COPD appeared first on MedCity News.
Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, retirements, promotions and layoffs occurring across the healthcare industry. The post Healthcare Moves: A Monthly Summary of Hires and Layoffs appeared first on MedCity News.
The FTC Is Suing PBMs Over Insulin Prices. Will It Be Successful?
The Federal Trade Commission has sued CVS Caremark, Express Scripts and Optum Rx, alleging that they engage in “anticompetitive and unfair rebating practices” as it relates to insulin. One legal expert believes the FTC might win this legal battle. The post The FTC Is Suing PBMs Over Insulin Prices. Will It Be Successful? appeared first…
The Harris Campaign is Right to Pledge More Resources For Senior Home Care, But the Devil Will Be in the Detail
What will happen in the fall remains to be seen, but the pledge is facilitating an open dialogue within the senior care industry about the problems it’s facing, along with some fresh thinking on potential solutions. The post The Harris Campaign is Right to Pledge More Resources For Senior Home Care, But the Devil Will…